IPO registrations (S-1, F-1) · Registrants

CG Oncology, Inc.

SEC CIK

1991792 · filings on EDGAR ↗

Registration

Form S-1, first filed 2024-01-02, last 2024-12-11; 2 initial registrations, 3 amendments

Outcome

Final prospectus filed 2024-01-25; declared effective 2024-01-24

Industry (SIC)

Biological Products, (No Diagnostic Substances) 2836

Incorporated in

DE

Business address

3000 PEGASUS PARK DRIVE, SUITE 1640, Dallas, TX 75247

EIN

37-1611499

Ticker

CGON (Nasdaq)

EDGAR entity type

operating

Insiders and CEO pay

CG Oncology, Inc. on the corporate pages

Offering terms

Proposed price range

$16.00–$18.00 per share (S-1/A filed 2024-01-23)

Final price

$19.00 per share, above the range (424B4 filed 2024-01-25, an initial public offering)

Shares sold

20,000,000

Gross proceeds

$380,000,000 before underwriting discounts and any over-allotment option

Listing

Nasdaq under the symbol CGON

Lead underwriters

Morgan Stanley; Goldman Sachs (7,000,000 shares); Cantor Fitzgerald (3,800,000 shares)

Syndicate

LifeSci Capital (1,200,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

On this site

• Business registration: CG Oncology, Inc. Fuzzy (name and state)
• Business registration: CG ONCOLOGY, INC. Fuzzy (name and state)
• Business registration: CG ONCOLOGY, INC. Fuzzy (name and state)
• Form 5500 plan sponsor: CG ONCOLOGY INC EXACT (EIN (EXACT))
• SEC filer: CG Oncology, Inc. EXACT (CIK (EXACT))

Filings 10

Prospectus pages read 2

Officers, directors and large holders Forms 3, 4 and 5

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Biological Products, (No Diagnostic Substances), TX first:

• ILEX ONCOLOGY INC TX
• HEMOBIOTECH, INC. TX
• Peloton Therapeutics, Inc. TX
• Alpha Cognition Inc. TX
• Instil Bio, Inc. TX
• Kiromic Biopharma, Inc. TX
• Taysha Gene Therapies, Inc. TX
• Voyager Acquisition Corp./Cayman Islands TX
• STEM CELL INNOVATIONS, INC. TX
• REPROS THERAPEUTICS INC. TX

More with this interest.

In other datasets, the same topic (Health) in TX:

• Nonprofit: AARON ALEXANDERS CLUB NICU (Nonprofits (IRS Form 990))

Interests: Biological Products, (No Diagnostic Substances) · Health